Publicly available resource monitors the development of therapies to treat and prevent disease
WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development of treatments and vaccines for COVID-19.
The tracker is available online at https://milkeninstitute.org/covid-19-tracker. It is developed and maintained by FasterCures, a center of the Milken Institute, with an Advisory Council comprised of a Nobel Laureate researcher, former FDA chiefs, and industry leaders.
“We seek to accelerate efforts to find new treatments or vaccines, amplify what’s working, hold the system and its players accountable, and expand the global discussion about how to create durable, long term solutions,” says Esther Krofah, executive director of FasterCures. “COVID-19 is putting that approach to the test. We hope to be a resource promoting effective approaches and strategies."
The Milken Institute COVID-19 vaccine development and treatment tracker is compiled from publicly available sources and will be updated regularly. It will grow to include FDA-approved indications where applicable, as well as basic information about the focus of each clinical trial.
The Milken Institute welcomes input on new treatments and vaccines in development. Please email [email protected] with tips.
Related Content
-
Economic impact of excess weight now exceeds $1.7 trillion, new Milken Institute report reveals
LOS ANGELES, Tuesday, October 30, 2018—The impact of obesity and overweight on the U.S. economy has eclipsed $1.7 trillion, an amount equivalent to 9.3 percent of the nation’s gross domestic product, according to a new Milken Institute...Read Article -
Milken Institute Global Conference Goes Virtual October 12-21, 2020
Los Angeles – August 5, 2020 – The Milken Institute Global Conference, an annual convening of global leaders in government, finance, health, academia, and philanthropy, will go fully virtual this fall from October 12-21, 2020. Building on...Read Article -
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce the individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding...Read Article -
Venture Philanthropy Legal Report: The Importance of An Interruption License
This report is one in a series on legal issues of interest to non-profit organizations engaged in or thinking about Venture Philanthropy work. It discusses the beginnings of Venture Philanthropy in drug development, the importance of an...Read Report -
The Costs of Chronic Disease in the U.S.
Americans' chronic health problems and diseases not only come at the expense of individuals well-being, they also constitute a massive burden on the U.S. economy. When including the costs of lost economic productivity, the total costs of...Read Report11 11Hugh Waters and Marlon Graf -
Supporting Wellness: Initial Findings from a Survey of Lived Experience and Research Priorities of Depression and Bipolar
In 2018, the Milken Institute Center for Strategic Philanthropy and the Depression and Bipolar Support Alliance collaborated to develop a first of its kind community survey. The goal was to learn about the experiences of people living with...Read Report -
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering the market and can identify multiple cancers early and simultaneously. These tests detect signals found in DNA that cancer cells shed into the...Read Report -
2022 Policy Priorities and Solutions
The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental and environmental health, we bring together the best ideas...Read Report -
Maternal Mortality Among Vulnerable US Communities
This report covers the alarming reality of maternal mortality in the United States, where the maternal mortality ratio (number of maternal deaths per 100,000 births) stands as one of the highest among Organisation for Economic Co-operation...View Research11
Katherine Sacks and Brooke Shearon -
Tambourine Philanthropies Commits Over $5 Million in New Funding for Research into ALS, in Partnership with the Milken Institute
WASHINGTON, DC (April 30, 2024) — Tambourine Philanthropies (Tambourine), in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is pleased to announce the recipients of its ALS...Read Article -
Milken Institute, Ann Theodore Foundation Release Fourth Round of Funding for Sarcoidosis Research, Announce Cycle Three Awardees
September 17, 2024 (Washington, DC) —The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation, today announced that more than $2.4 million in funding is...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence. -
Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
Dr. Patrizia Cavazzoni Director, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring, MD 20993 Dr. Peter Marks Director, Center for Biologics Evaluation and Research US Food and Drug Administration Silver...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.